Anti-MFSD4A monoclonal antibody

Pre-made anti-MFSD4A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MFSD4A/MFSD4A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1181-Ab-1/ GM-Tg-hg-IP1181-Ab-2Anti-Human MFSD4A monoclonal antibodyHuman
GM-Tg-rg-IP1181-Ab-1/ GM-Tg-rg-IP1181-Ab-2Anti-Rat MFSD4A monoclonal antibodyRat
GM-Tg-mg-IP1181-Ab-1/ GM-Tg-mg-IP1181-Ab-2Anti-Mouse MFSD4A monoclonal antibodyMouse
GM-Tg-cynog-IP1181-Ab-1/ GM-Tg-cynog-IP1181-Ab-2Anti-Cynomolgus/ Rhesus macaque MFSD4A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1181-Ab-1/ GM-Tg-felg-IP1181-Ab-2Anti-Feline MFSD4A monoclonal antibodyFeline
GM-Tg-cang-IP1181-Ab-1/ GM-Tg-cang-IP1181-Ab-2Anti-Canine MFSD4A monoclonal antibodyCanine
GM-Tg-bovg-IP1181-Ab-1/ GM-Tg-bovg-IP1181-Ab-2Anti-Bovine MFSD4A monoclonal antibodyBovine
GM-Tg-equg-IP1181-Ab-1/ GM-Tg-equg-IP1181-Ab-2Anti-Equine MFSD4A monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1181-Ab-1/ GM-Tg-hg-IP1181-Ab-2; GM-Tg-rg-IP1181-Ab-1/ GM-Tg-rg-IP1181-Ab-2;
GM-Tg-mg-IP1181-Ab-1/ GM-Tg-mg-IP1181-Ab-2; GM-Tg-cynog-IP1181-Ab-1/ GM-Tg-cynog-IP1181-Ab-2;
GM-Tg-felg-IP1181-Ab-1/ GM-Tg-felg-IP1181-Ab-2; GM-Tg-cang-IP1181-Ab-1/ GM-Tg-cang-IP1181-Ab-2;
GM-Tg-bovg-IP1181-Ab-1/ GM-Tg-bovg-IP1181-Ab-2; GM-Tg-equg-IP1181-Ab-1/ GM-Tg-equg-IP1181-Ab-2
Products NameAnti-MFSD4A monoclonal antibody
Formatmab
Target NameMFSD4A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MFSD4A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1181-Ag-1Recombinant multi-species MFD4A/ MFSD4A/ MFSD4 protein


    Target information

    Target IDGM-IP1181
    Target NameMFSD4A
    Gene ID148808,213006,498228,697813,478943,101086112,515128,100055030
    Gene Symbol and SynonymsA230072B04,A930031D07Rik,MFSD4,MFSD4A,RGD1566090,SLC60A1,UNQ3064
    Uniprot AccessionQ8N468
    Uniprot Entry NameMFD4A_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000174514
    Target ClassificationN/A

    The target: MFSD4A, gene name: MFSD4A, also named as MFSD4, UNQ3064. Predicted to enable glucose transmembrane transporter activity. Predicted to be involved in glucose transmembrane transport. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.